| Sep 27 |
Novel combination of TALVEY® (talquetamab-tgvs) and TECVAYLI® (teclistamab-cqyv) suggests high response rates and durable responses in triple-class refractory patients with relapsed or refractory multiple myeloma, including those with extramedullary di...
|
| Sep 27 |
TALVEY® (talquetamab-tgvs) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) based combination shows deep and durable responses in patients with relapsed or refractory multiple myeloma
|
| Sep 26 |
J&J snaps six straight sessions of losses
|
| Sep 26 |
Is Johnson & Johnson (JNJ) the Best Stock To Buy Right Now According To Billionaire Cliff Asness?
|
| Sep 26 |
J&J to shutter cardiovascular, metabolic drug unit: report
|
| Sep 26 |
Johnson & Johnson (JNJ): Leveraging Innovation for Sustained Market Leadership
|
| Sep 26 |
Johnson & Johnson (JNJ): A Good Undervalued Blue Chip Stock to Buy According to Analysts
|
| Sep 26 |
Johnson & Johnson (JNJ): A Good Holding Company Stock to Buy Now
|
| Sep 25 |
Johnson & Johnson (JNJ): Hedge Funds Are Bullish On This Trending AI Stock Right Now
|
| Sep 25 |
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
|
